Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Optimization Criteria and Efficiency of a Thermoelectric Generator.

Entropy (Basel, Switzerland)·2022

Same author

Influence of multi-walled carbon nanotubes on the physico-chemical and biological responses of chitosan-based hybrid hydrogels.

Carbohydrate polymers·2020

Same author

Dendritic Immunotherapy Improvement for an Optimal Control Murine Model.

Computational and mathematical methods in medicine·2017

Same author

On a mathematical model of bone marrow metastatic niche.

Mathematical biosciences and engineering : MBE·2016

Same author

Nonlinear stability of a heterogeneous state in a PDE-ODE model for acid-mediated tumor invasion.

Mathematical biosciences and engineering : MBE·2016

Same author

On a mathematical model of tumor growth based on cancer stem cells.

Mathematical biosciences and engineering : MBE·2013

Search research articles

Related Experiment Video

Updated: Apr 11, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Enhancing dendritic cell immunotherapy for melanoma using a simple mathematical model.

E Castillo-Montiel¹, J C Chimal-Eguía², J Ignacio Tello³

¹Laboratorio de Modelación y Simulación, Centro de Investigación en Computación, Instituto Politécnico Nacional, Av. Juan de Dios Bátiz, Esq. Miguel Othón de Mendizábal, Del. Gustavo A. Madero, México City, 07738, México. erandicm@sagitario.cic.ipn.mx.

Theoretical Biology & Medical Modelling

|June 10, 2015

Summary

This study developed a mathematical model for dendritic cell (DC) immunotherapy against melanoma. The model accurately simulates tumor growth and suggests optimizing DC doses and infusion times can improve treatment effectiveness.

More Related Videos

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

Related Experiment Videos

Last Updated: Apr 11, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

Area of Science:

Immunology
Mathematical Biology
Computational Oncology

Background:

Dendritic cell (DC) immunotherapy is an explored approach for cancer treatment, inducing specific immune responses.
This research focuses on a mathematical model for DC immunotherapy targeting melanoma in mice, based on work from UNAM.

Purpose of the Study:

To create and validate a mathematical model simulating DC immunotherapy for melanoma.
To explore potential improvements in immunotherapy protocols through computational analysis.

Main Methods:

A five delay differential equation (DDE) model was developed, incorporating tumor cells, DCs, T lymphocytes, effector cells, and TGF-β.
Model validation involved comparing simulation results with biological trial data from UNAM.

Main Results:

The simulation accurately reflected control immunotherapy tumor cell populations, with ~10% error compared to biological data.
Numerical simulations indicated that increased DC doses and adjusted infusion times could reduce tumor growth.
Sensitivity analysis identified key parameters influencing the model: time delay (τ), tumor growth rate (r), and cytotoxic cell efficiency (aT).

Conclusions:

The mathematical model provides a reliable approximation of biological trial data for melanoma immunotherapy.
Model manipulation suggests that optimizing immunotherapy protocols, such as altering DC dosage and infusion schedules, can enhance treatment efficacy.
These findings offer a framework for the UNAM Immunotherapy Laboratory to refine their treatment strategies.